
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Findings from the survey suggest that certain symptoms of depression could help identify patients vulnerable to both worsening psoriasis symptoms and disease-related quality of life (QoL).

Parental asthma is strongly linked to higher asthma risk in offspring, with no strong difference found between mothers and fathers, according to a recent study.

Interviews with 2241 men who have sex with men (MSM) without HIV showed high levels of HIV testing, but lower levels of preventative treatment in 2021.

The Biden administration released 2 sets of guidance documents for pharmaceutical manufacturers about how it plans to implement the new Medicare Prescription Drug Inflation Rebate Program as required under the Inflation Reduction Act, and said some beneficiaries could see lower coinsurance for some Part B drugs as soon as April 1.

Kirk Campbell, MD, FASN, Vice Chair for Diversity, Equity, and Inclusion in the Department of Medicine at Mount Sinai Health System in New York, spoke on educational initiatives implemented by Mount Sinai to train resident physicians, medical students, and senior faculty on health equity, as well as further research efforts to address disparities.

The Advisory Committee on Immunization Practices released the update to the Recommended Adult Immunization Schedule for all US residents aged 19 years and older, which has been approved by the CDC and medical groups.

Chimeric antigen receptor T-cell therapy brexucabtagene autoleucel showed a rate of complete remission of 71% and a rate of complete remission with incomplete hematologic recovery of 56%, according to 3-year follow-up results.

Jessica Allegretti, MD, MPH, medical director of the Crohn's and Colitis Center, Brigham and Women's Hospital, discussed how the FDA’s approval of Rebyota for the prevention of recurrent Clostridioides difficile infection (CDI) may promote cost effective management of CDI for patients and health systems.

While treatment with allogeneic hematopoietic cell transplantation (allo-HCT) showed improved disease-free survival compared with conventional consolidation chemotherapy, the findings suggest there may not be an overall survival (OS) benefit with allo-HCT for patients with intermediate-risk acute myeloid leukemia (AML) during first complete remission.

A randomized controlled trial found that the use of a rectal spacer may help mitigate the gastrointestinal (GI) toxicity associated with hypofractionated radiation therapy for prostate cancer.

China’s angry reaction after spy balloon retrieval rouses drug supply chain anxiety; after allegedly overcharging California’s Medi-Cal program, managed care company Centene will pay millions in a settlement; major drug companies are chasing new pharma deals amidst dropping patent exclusivity.

Michael N. Cohen, MD, FAAO, retinal surgeon at Wills Eye Hospital in Philadephia and Mid Atlantic Retina, speaks about the future of gene therapy and the accessibility and availability of these therapies moving forward.

Gender-specific chronic obstructive pulmonary disease (COPD) symptoms identify differences among men and women as good predictors for cardiac comorbidities.

A study of patients hospitalized for chronic obstructive pulmonary disease (COPD) exacerbation found that exclusively using the population-based Hospital Frailty Risk Score tool to assess for frailty may cause it to go undetected and untreated.

The Angiogenesis, Exudation, and Degeneration 2023 meeting will be held virtually with a program focused on understanding and treating neovascular, exudative, and degenerative diseases of the eye.

The authors conducted a subanalysis of data on 100,000-plus children from 3 studies to estimate the global prevalence and severity of eczema; they used linear mixed models to do so.

The findings emphasize a need for policies that may offset the impact of direct and indirect costs for patients with breast cancer.

Biden’s State of the Union (SOTU) address emphasized drug access for those on Medicare, the Cancer Moonshot, and more; HIV diagnoses are increasing in Washington, DC, from missed wellness visits and preventive visits upended during the start of COVID-19; California online women’s pharmacy The Pill Club will pay $18.3 million in Medicaid fraud settlement with California.

The report helps clarify the urban/rural divide in cancer outcomes and the digital divide in telehealth access.

The effects of physical activity and exercise have previously been reported, with data pointing to improvements in quality of life as well as such clinical markers as immune response in tumors

The method had high rates of sensitivity and specificity, although its sensitivity was somewhat lower in cases of localized prostate cancer.

Data released in the CDC’s latest Morbidity and Mortality Weekly Report indicate that patients with end-stage kidney disease on hemodialysis who are Black, Hispanic/Latino, or of lower socioeconomic status (SES) are at greater risk of Staphylococcus aureus bloodstream infections, with Hispanic/Latino ethnicity cited as an independent risk factor.

On this episode of Managed Care Cast, we speak with Tom Stanis, CEO and cofounder of Story Health, and Phillip Wood, Intermountain Ventures program director, on how their partnership came about, how it is going so far, and the future of their collaboration.

The increasing numbers of people driving electric vehicles in California has been linked to a reduction in respiratory symptoms, such as asthma, and lower levels of air pollution.

CVS Health Corp. is nearing a $10.5 billion deal to take on Oak Street Health Inc.; an innovative cystic fibrosis drug that can lengthen life expectancy for patients is blocked by high costs and unavailability in low-income countries; New York City will end the COVID-19 vaccine mandate for city workers.

The investigational therapy promises a new way to target HER2 while still using chemotherapy combinations.

Artificial intelligence (AI) improved detection of actionable lung nodules without leading to higher rates of false positives, the study found.

Drug costs, particularly for immunotherapies, contributed to the rising cost of care during the last 6 months of life for a fee-for-service Medicare beneficiary, according to a recent study.

Amy Crawford-Faucher, MD, vice chair of the Primary Care Institute and Department of Family Medicine at Allegheny Health Network, discussed the potential of a respiratory syncytial virus vaccine in children, as well as ongoing efforts to get childhood vaccination rates back on track.

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
